These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. It May Not Be Too Little or Too Late: Resecting Primary Small Bowel Neuroendocrine Tumors in the Presence of Metastatic Disease. Howe JR Ann Surg Oncol; 2020 Aug; 27(8):2583-2585. PubMed ID: 32500346 [No Abstract] [Full Text] [Related]
9. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making. Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290 [TBL] [Abstract][Full Text] [Related]
10. The liver halo sign after tumor ablation. Ronot M; Bouda D; Vilgrain V J Vasc Interv Radiol; 2014 Oct; 25(10):1641-3. PubMed ID: 25255949 [No Abstract] [Full Text] [Related]
11. Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor. Wettstein M; Vogt C; Cohnen M; Brill N; Kurz AK; Mödder U; Häussinger D Hepatogastroenterology; 2004; 51(57):830-2. PubMed ID: 15143927 [TBL] [Abstract][Full Text] [Related]
13. [Surgical aspects of neuroendocrine tumors of the small intestine]. Weber F; Dralle H Chirurg; 2018 Jun; 89(6):428-433. PubMed ID: 29464306 [TBL] [Abstract][Full Text] [Related]